Term
|
Definition
· thickening or hardening of the arterial wall
· innermost layer undergoes a series of changes that ¯ the artery’s ability to change lumen size
|
|
|
Term
Clinical Manifestations of Atherosclerosis |
|
Definition
· Manifestations depend on
* Vessel involved
* Site of the lesion
* Age of patient
* Genetic makeup
* Physiologic status of the individual
· HTN develops if atherosclerosis systemic vascular resistance (SVR)
· Cerebral or myocardial ischemia is a life-threatening manifestation of atherosclerosis in vessels of the brain or heart
|
|
|
Term
Atherosclerosis: Physical Assessment |
|
Definition
· Assess BP in both arms
· Palpate pulses – note differences
· Palpate skin temperature in lower extremities
· Assess cap refill prolonged > 3 seconds in young to middle aged adults; > 5 seconds in older adults
|
|
|
Term
Atherosclerosis: laboratory assessment |
|
Definition
Serum Cholesterol (HDL+LDL+1/5 Triglyceride Level)
▪ Desirable – < 200 mg/dL
▪ Borderline High Risk – 200 – 239 mg/dL
▪ High Risk – 240 mg/dL and over
|
|
|
Term
|
Definition
|
|
Term
|
Definition
© Levels indicate a persons risk for atherosclerosis
© LDL’s deposit cholesterol in lining of vessels
Desirable LDL-C level < 100 mg/dL for all individuals (and for extremely high risk patients < 70 mg/dL |
|
|
Term
|
Definition
© HDL’s carry cholesterol away from the arteries to the liver, where the cholesterol can be processed into a harmless substance and excreted from the body
© HDL cholesterol has been compared to "janitors" in the arteries – there are 5 subclasses of HDL seen with special electrophoresis
© Desirable HDL–C > 40 mg/dL men
> 50 mg/dL women
© Low HDL puts one at high risk for heart disease
© High HDL ³ 60 mg/dL considered protective against CAD
|
|
|
Term
Triglycerides: lab ranges
|
|
Definition
▪ normal < 150 mg/dL
▪ 150 – 190 mg/dL are borderline high
▪ Levels > 200 mg/dL are high
|
|
|
Term
|
Definition
* One of the acute phase proteins that inc. during systemic inflammation
▪ Inflammation is a common component to the development of lipid containing plaques
* Level < 1 mg/dL considered low risk; level > 3 mg/dL risk heart disease
* Marker for CV events
* CRP consistently > 10 may indicate other noncardiac causes of inflammation
* Can decrease with ASA, exercise, statins
|
|
|
Term
|
Definition
Therapeutic Lifestyle Changes (TLC)
Smoking Cessation
Exercise
Drug Therapy (Anti lipemics)
|
|
|